Your browser doesn't support javascript.
loading
Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology [The]. 2009; 15 (4): 283-287
en Inglés | IMEMR | ID: emr-102147
ABSTRACT
Ulcerative colitis is a chronic inflammatory disease that affects the colon and rectum. Its pathogenesis is probably multifactorial including the influx of certain cytokines into the colonic mucosa, causing disease activity and relapse. The hypothesis of removing such cytokines from the circulation by leukocytapheresis was implemented to reduce disease activity, maintain remission, and prevent relapse. Many recent reports not only in Japan, but also in the West, have highlighted its beneficial effects in both adult and pediatric patients. Large placebo-controlled studies are needed to confirm the available data in this regard. In this article, we shed some light on the use of leukocyte apheresis in the management of autoimmune diseases, especially ulcerative colitis
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Enfermedades Autoinmunes / Colitis Ulcerosa / Leucaféresis Límite: Humanos Idioma: Inglés Revista: Saudi J. Gastroenterol. Año: 2009

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Enfermedades Autoinmunes / Colitis Ulcerosa / Leucaféresis Límite: Humanos Idioma: Inglés Revista: Saudi J. Gastroenterol. Año: 2009